Larsson C
Contrib Nephrol. 1978;12:82-91.
The renal prostaglandins (PGs) are formed mainly in the endoplasmatic reticulum from locally available precursor, arachidonic acid (C20:4). Although the main PG formation occurs in the papilla, significant amounts of PGs are also formed in the cortex. PGs are not stored, but at once released to the cytosol and metabolized by soluble enzymes, 15-OH-PG-dehydrogenase (PGDA), delta13-PG-reductase and PGE-9-keto-reductase. PG metabolism by the PGDH pathway occurs predominantly in cortex. C20:4 can be used to study the biological effects of the renal PG system. C20:4 given to rabbits increases renal biosynthesis of PGs, renal blood flow, predominantly in the juxtamedullary cortex, and plasma renin activity. These effects are inhibited by PG synthesis inhibitors like indomethacin.
肾脏前列腺素(PGs)主要在内质网中由局部可得的前体花生四烯酸(C20:4)形成。虽然主要的PG形成发生在乳头,但皮质中也会形成大量的PGs。PGs不会储存,而是立即释放到细胞质中,并由可溶性酶15-羟基-PG脱氢酶(PGDA)、δ13-PG还原酶和PGE-9-酮还原酶代谢。通过PGDH途径的PG代谢主要发生在皮质。C20:4可用于研究肾脏PG系统的生物学效应。给兔子注射C20:4会增加PGs的肾脏生物合成、肾脏血流量,主要是在近髓质皮质,以及血浆肾素活性。这些效应会被吲哚美辛等PG合成抑制剂抑制。